Results 101 to 110 of about 6,597 (237)

Chronic Prurigo

JDDG: Journal der Deutschen Dermatologischen Gesellschaft
SummaryChronic prurigo (CPG) is a neuroinflammatory dermatosis characterized by prolonged pruritus lasting more than 6 weeks, pruriginous skin lesions, and repeated scratching.Patients with CPG suffer significantly from psychological distress and a marked impairment in their quality of life.
Julia Thünemann, Svenja Müller, Kerstin Steinbrink, Sonja Ständer, Claudia Zeidler   +4 more
openaire   +2 more sources

A Rare Case of Prurigo Pigmentosa in Iranian Sibling Couple

Clinical Case Reports
Prurigo Pigmentosa is a rare inflammatory skin disease of unknown origin, characterized by pruritic, erythematous papules on the chest, back, neck, and anterior abdomen. The eruption resolves with reticular hyperpigmentation that cosmetically affects the
Saman Al‐Zahawi, Fatemeh Saberi, Vahidesadat Azhari, Kambiz Kamyab, Kamran Balighi   +4 more
doaj   +1 more source

Cost-effectiveness Analysis of Dupilumab for the Treatment of Adult Patients with Severe Prurigo Nodularis in Italy

Acta Dermato-Venereologica
Prurigo nodularis is characterized by intensely pruritic nodules that significantly impact patients’ quality of life. This study aims to evaluate the cost-effectiveness of dupilumab compared with the best supportive care for the treatment of severe ...
Cataldo Patruno, Massimiliano Povero, Andrea Tassone, Maria Paola Pedone, Donia Bahloul, Jules Tavi, Paolo Amerio   +6 more
doaj   +1 more source

Model‐informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis

British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1744-1759, June 2026.
Abstract Aims Population pharmacokinetic (popPK) and pharmacokinetic‐pharmacodynamic (PK/PD) models were developed to support clinical development of nemolizumab, a humanized monoclonal antibody targeting the IL‐31 receptor α, in adolescents and adults with moderate‐to‐severe atopic dermatitis (AD).
Floris Fauchet, Anna Largajolli, Petra M. Jauslin, Emilie Schindler, Mourad Hamimed, Wannee Kantasiripitak, Antonio Gonçalves, Eline Van Maanen, Khaled Benkali, Tomohisa Saito, Jonathan I. Silverberg, Andreas Wollenberg, Michael Graeber, Liliana Ulianov, Christophe Piketty, Luca Loprete, Vincent Duval, Nathalie Wagner   +17 more
wiley   +1 more source

Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal, Roshanay Ejaz Awan, Hur Abbas, Zahra Sania, Ashna Habib, Syeda Kaneez Sakina, Amina Mahmud, Mohammed Mahmmoud Fadelallah Eljack   +7 more
wiley   +1 more source

Prevalence and Burden of Somatic Symptom Disorder in Atopic Dermatitis and Chronic Pruritus—The Persistent Somatic Symptoms Across Diseases: Pruritus (SOMA.PRU) Study

JEADV Clinical Practice, Volume 5, Issue 2, Page 486-494, June 2026.
In adults with atopic dermatitis and chronic pruritus, the mental comorbidity of Somatic Symptom Disorder is associated with higher average and worst pruritus intensity, higher psychological distress and lower quality of life. Additionally, there were nonsignificant changes in cutaneous nerve fiber densities in skin biopsies.
Stefan M. Kahnert, Ansgar Koechel, Gina L. Frank, Svenja Royeck, Claudia Zeidler, Felix Witte, Christian Mess, Konstantin Agelopoulos, Volker Huck, Bernd Löwe, Rupert Conrad, Gudrun Schneider, Stefan W. Schneider, Sonja Ständer   +13 more
wiley   +1 more source

A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With Dupilumab

JEADV Clinical Practice, Volume 5, Issue 2, Page 644-647, June 2026.
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou, Sharon Edwards, Andrew Affleck   +2 more
wiley   +1 more source

Prurigo y fototerapia, el manejo multidisciplinario del prurigo crónico

, 2022
Prurigo is a chronic disease consisting of the formation of pruritic nodules or papules, secondary topersistent scratching of the injured area, caused by allergic reactions, systemic and/or metabolicdiseases and can greatly affect the quality of life of ...
Gómez Murillo, Daniela, Beltrán Gutiérrez, Dafni Natali, Puentes, Juan Sebastián, Rodríguez Umaña, Víctor Manuel, Baez Pinzón, Luisa Fernanda, Zamorano Ferrer, Nathalie   +5 more
core  

Unusually Widespread Occupational Allergic Contact Dermatitis From 1,3‐Diphenylguanidine in a Surgical Resident

Contact Dermatitis, Volume 95, Issue 1, Page 109-112, July 2026.
Goël Fenech, Lynda Bensefa‐Colas, Eddy Langlois, Eric Pelletier, Marie‐Noëlle Crepy   +4 more
wiley   +1 more source

Early Stage Prurigo Pigmentosa : A Case Report

, 2018
Prurigo pigmentosa is a rare inflammatory dermatosis that primarily affects adolescents and young adults. Even though it is most commonly seen in Japanese women, other countries have reported cases with increasing frequency.
Songur, Abdullah, Zekayi KUTLUBAY, Demirkesen, Cuyan, Onaygil, Emel, Emel ONAYGİL, Abdullah SONGUR, Cuyan DEMİRKESEN, Kutlubay, Zekayi   +7 more
core   +1 more source